| Ebola virus disease ST Jacob, I Crozier, WA Fischer, A Hewlett, CS Kraft, MAL Vega, MJ Soka, ... Nature reviews Disease primers 6 (1), 13, 2020 | 554 | 2020 |
| Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses AZ Wec, AS Herbert, CD Murin, EK Nyakatura, DM Abelson, JM Fels, ... Cell 169 (5), 878-890. e15, 2017 | 160 | 2017 |
| The multiple roles of sGP in Ebola pathogenesis MA de La Vega, G Wong, GP Kobinger, X Qiu Viral immunology 28 (1), 3-9, 2015 | 134 | 2015 |
| Ebola viral load at diagnosis associates with patient outcome and outbreak evolution MA de La Vega, G Caleo, J Audet, X Qiu, RA Kozak, JI Brooks, S Kern, ... The Journal of clinical investigation 125 (12), 4421-4428, 2015 | 126 | 2015 |
| DNA vaccination protects mice against Zika virus-induced damage to the testes BD Griffin, K Muthumani, BM Warner, A Majer, M Hagan, J Audet, ... Nature communications 8 (1), 15743, 2017 | 101 | 2017 |
| Ferrets infected with Bundibugyo virus or Ebola virus recapitulate important aspects of human filovirus disease R Kozak, S He, A Kroeker, MA de La Vega, J Audet, G Wong, C Urfano, ... Journal of Virology 90 (20), 9209-9223, 2016 | 77 | 2016 |
| Ebolavirus evolution: past and present MA de La Vega, D Stein, GP Kobinger PLoS pathogens 11 (11), e1005221, 2015 | 77 | 2015 |
| Ebola virus in breast milk in an Ebola virus–positive mother with twin babies, Guinea, 2015 H Nordenstedt, EI Bah, MA de la Vega, M Barry, M N’Faly, M Barry, ... Emerging Infectious Diseases 22 (4), 759, 2016 | 52 | 2016 |
| Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses PF Simon, MA de La Vega, É Paradis, E Mendoza, KM Coombs, ... Scientific Reports 6 (1), 24154, 2016 | 46 | 2016 |
| Protective efficacy and long-term immunogenicity in cynomolgus macaques by Ebola virus glycoprotein synthetic DNA vaccines A Patel, EL Reuschel, KA Kraynyak, T Racine, DH Park, VL Scott, J Audet, ... The Journal of infectious diseases 219 (4), 544-555, 2019 | 37 | 2019 |
| Pathogenicity comparison between the Kikwit and Makona Ebola virus variants in rhesus macaques G Wong, X Qiu, MA de La Vega, L Fernando, H Wei, A Bello, ... The Journal of infectious diseases 214 (suppl_3), S281-S289, 2016 | 34 | 2016 |
| Successful control of Ebola virus disease: analysis of service based data from rural Sierra Leone K Lokuge, G Caleo, J Greig, J Duncombe, N McWilliam, J Squire, ... PLoS neglected tropical diseases 10 (3), e0004498, 2016 | 34 | 2016 |
| Characterization of Sudan Ebolavirus infection in ferrets A Kroeker, S He, MA de La Vega, G Wong, C Embury-Hyatt, X Qiu Oncotarget 8 (28), 46262, 2017 | 32 | 2017 |
| The makona variant of ebola virus is highly lethal to immunocompromised mice and immunocompetent ferrets G Wong, A Leung, S He, W Cao, MA De La Vega, BD Griffin, G Soule, ... The Journal of Infectious Diseases 218 (suppl_5), S466-S470, 2018 | 19 | 2018 |
| Marburg and Ravn virus infections do not cause observable disease in ferrets G Wong, Z Zhang, S He, MA de La Vega, K Tierney, G Soule, K Tran, ... The Journal of Infectious Diseases 218 (suppl_5), S471-S474, 2018 | 19 | 2018 |
| Modeling Ebola virus transmission using ferrets MA de La Vega, G Soule, KN Tran, K Tierney, S He, G Wong, X Qiu, ... Msphere 3 (5), 10.1128/msphere. 00309-18, 2018 | 18 | 2018 |
| Diagnosis and management of Ebola samples in the laboratory MA de La Vega, A Bello, P Chaillet, GP Kobinger Expert Review of Anti-infective Therapy 14 (6), 557-567, 2016 | 15 | 2016 |
| Zika-induced male infertility in mice is potentially reversible and preventable by deoxyribonucleic acid immunization MA de La Vega, J Piret, BD Griffin, C Rhéaume, MC Venable, ... The Journal of Infectious Diseases 219 (3), 365-374, 2019 | 14 | 2019 |
| Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters GG Babuadze, H Fausther-Bovendo, MA Delavega, B Lillie, ... npj Vaccines 7 (1), 49, 2022 | 9 | 2022 |
| SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants MA de La Vega, E Polychronopoulou, A Xiii, Z Ding, T Chen, Q Liu, J Lan, ... Emerging Microbes & Infections 12 (1), e2169198, 2023 | 8 | 2023 |
Xiangguo QiuResearch scientist, NML-Canada在 canada.ca 的电子邮件经过验证
